{
  "@context": {
    "@vocab": "http://schema.org/",
    "rdau": "http://rdaregistry.info/Elements/u/",
    "skos": "http://www.w3.org/2004/02/skos/core#",
    "skos:prefLabel": {
      "@container": "@language"
    }
  },
  "@graph": [
    {
      "@id": "http://urn.fi/URN:NBN:fi:bib:me:W00567730700",
      "about": {
        "@id": "http://www.yso.fi/onto/yso/p19663"
      },
      "name": "The application of enzyme replacement therapy in vitro and in a mouse model in aspartylglycosaminuria"
    },
    {
      "@id": "http://urn.fi/URN:NBN:fi:bib:me:W00334948100",
      "about": {
        "@id": "http://www.yso.fi/onto/yso/p19663"
      },
      "name": "The clinical use of glycosylasparaginase and L-asparaginase assays"
    },
    {
      "@id": "http://www.yso.fi/onto/yso/p19663",
      "name": "aspartyyliglukosaminuria"
    },
    {
      "@id": "http://urn.fi/URN:NBN:fi:bib:me:W00614956100",
      "about": {
        "@id": "http://www.yso.fi/onto/yso/p19663"
      },
      "name": "Catalytic and therapeutic characteristics of human recombinant glycosylasparaginase and bacterial L-asparaginases"
    },
    {
      "@id": "http://urn.fi/URN:NBN:fi:bib:me:W00236558900",
      "about": {
        "@id": "http://www.yso.fi/onto/yso/p19663"
      },
      "name": "Characterization of aspartylglucosaminidase activation and aspartylglucosaminuria mutations"
    }
  ]
}